Clinical Trial Update: Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating add-on peginterferon after nucleos(t)ide analogue therapy for chronic hepatitis B has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon (Pegylated interferon)
• nucleos(t)ide analogue (nucleos(t)ide analogue)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2019-08-28